SUPN NASDAQ · Healthcare · FY 2025-12-31
SUPERNUS PHARMACEUTICALS, INC.
ABV
EPV
EBV
DBV
fair value / share
buy at or below (margin of safety applied)
margin-of-safety band
current price
values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Franchise
Confidence
●●○
Medium · 2/4
Price
44.630 USD
Market cap
2.56B USD
P / B
2.42
P / E
—
EPS
-0.680
DPS / yield
— (0.0%)
NAV / share
6.394
Graham number
—
Z'' score
5.17
Piotroski F
4 / 9
Beneish M
-2.54
ROIC vs WACC
-4.6%
vs 7.9%
See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.
Subscribe to unlock this and every other tab for every company.
See the full ABV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EPV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full DBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.